BVS vs BXP · rev $573.3M vs rev $3.48B
Bioventus Inc (BVS) versus Boston Properties Inc (BXP) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
BVS currently screens at market cap $495.1M. BXP currently screens at market cap $12.12B.
Not investment advice. Open the BVS and BXP stock pages for the full models.
Not investment advice.